Product Images Brimonidine Tartrate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Brimonidine Tartrate NDC 82182-773 by Pacific Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text is a description of Brimonidine tartrate 0.15% solution used in ophthalmic treatments. It mentions the NDC code and suggests it should be used once in each eye per day. The text also lists the ingredients and the trademarks of the respective owners. The recommended storage temperature is between 15°C to 25°C.*
This is a product description of Brimonidine Tartrate ophthalmic solution 0.15%. It contains ingredients such as brimonidine tartrate, boric acid, calcium chloride, and potassium chloride. It also has a preservative called water URITE. The usual dosage requires using it three times a day or as directed by a physician. The product is patented, and the trademarks belong to their respective owners. It's distributed by Alergan, and the patent information can be found on their website. The storage instructions recommend storing it at 15-25 ºC.*
Brimonidine tartrate is an ophthalmic solution used to treat intraocular pressure in patients with glaucoma or ocular hypertension. The solution is 0.15%. The product is patented and manufactured in India. The solution contains various inactive ingredients such as boric acid, potassium chloride, and sodium chloride. The recommended dosage is one drop in the affected eye(s) every eight hours. The solution should be stored at 15-25°C.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.